Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer

Aflibercept plus 5‐fluorouracil/levofolinate/irinotecan (FOLFIRI) is a second‐line treatment for metastatic colorectal cancer. This ancillary exploratory analysis of data in Japanese people was aimed at exploring the relationship between a set of potential prognostic biomarkers and efficacy endpoint...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamaguchi, Tetsuya, Denda, Tadamichi, Kudo, Toshihiro, Sugimoto, Naotoshi, Ura, Takashi, Yamazaki, Kentaro, Fujii, Hirofumi, Kajiwara, Takeshi, Nakajima, Takako Eguchi, Takahashi, Shin, Otsu, Satoshi, Komatsu, Yoshito, Nagashima, Fumio, Moriwaki, Toshikazu, Esaki, Taito, Sato, Takeo, Itabashi, Michio, Oki, Eiji, Sasaki, Toru, Chiron, Marielle, Yoshino, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825011/
https://www.ncbi.nlm.nih.gov/pubmed/31520559
http://dx.doi.org/10.1111/cas.14198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825011/
https://www.ncbi.nlm.nih.gov/pubmed/31520559
http://dx.doi.org/10.1111/cas.14198

Ejemplares similares